Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2008-08-01

Original market date: See footnote 1

1999-09-28

Product name:

RATIO-IPRATROPIUM

DIN:

02240072 Electronic product monograph is not available

Company:

RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Metered-Dose Pump

Route(s) of administration:

Nasal

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

12:08.08 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R01AX03 IPRATROPIUM BROMIDE

Active ingredient group (AIG) number:See footnote5

0115643002

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
IPRATROPIUM BROMIDE 21 MCG / ACT
Version 4.0.3

"Page details"

Date modified: